Trial design, systematic reviews, medical statistics, and guideline updates.
An article joins this feed when it matches these terms. Each one is also a search of its own.
Faron Pharmaceuticals enrolled the first patient in the Phase 1b/2 BEXAR investigator-initiated trial. The BEXAR trial evaluates Faron's lead asset, bexmarilimab, in combination with standard-of-care... Faron Pharmaceuticals enrolled the first patient in the Phase 1b/2 BEXAR investigator-initiated trial The BEXAR trial evaluates…
Clinical Anatomy & Kinesiology (CAK) | Project ATLAS Phase 5 Physiology, Pain Science, and Evidence Edition Placebo and nocebo effects are phenomena where expectations, learning, and the treatment context influence the experience of symptoms. This is not a concept that advocates for deceptive…
Slide Presentation: Efficacy and Safety of the Oral PCSK9 Inhibitor, MK-0616, a Macrocyclic Peptide, in the Treatment of Hypercholesterolemia: A Phase 2b Randomized Placebo-Controlled Clinical Trial
Regeneron Pharmaceuticals, Inc. announced that the European Medicines Agency?s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the approval of an... announced that the European Medicines Agency?s (EMA) Committee for Medicinal Products for…
Disc Medicine will host a webcast on October 19, 2026, to discuss APOLLO Phase 3 trial results for bitopertin. The APOLLO Phase 3 trial evaluates the efficacy of bitopertin for treating erythropoietic porphyrias (EPP). The corporate webcast will be held on Monday, October 19, 2026, at…
Ruiling Yuan, Adjunct Assistant Professor at Edward Via College of Osteopathic Medicine, shared a post by Joanna Metzner-Sadurski, Assistant Professor at Edward Via College of Osteopathic Medicine, Founder and Executive Director of Oncology101.org, adding: “Finding a clinical trial is important,…
At the Community Oncology Global Congress (COGC 2026), organized by OncoDaily, Jenny Ahlstrom, Founder and CEO of the HealthTree Foundation, discussed how patient-owned health data and digital infrastructure could support more distributed clinical trials, particularly for patients who cannot easily travel…
Yara Abdou, Assistant Professor at University of North Carolina at Chapel Hill, shared on X: “What will it take to make cancer clinical trials more accessible? A survey of 260 patients and 80 oncologists identified major barriers: treatment concerns, financial burden, logistics, and…
Bionic eyes are advancing beyond science fiction, with newer implants helping some people regain functional vision. From chips that stimulate the retina to devices that could eventually offer optical zoom, thermal imaging and night vision, researchers are exploring how technology…